Rare Disease Pricing Strategy: Global Glomerulonephritis Market Research

Leverage primary research across four key markets (US, DE, CN, JP) to determine key pricing and market access considerations for oral product for glomerulonephritis indications and systemic sclerosis.

• Conduct brief landscape assessment to identify key competitors and potential price benchmarks
• Conduct US payer research for GN and SSc separately to understand indication-specific pricing potential and anticipated coverage of the product 
• Conduct ex-US payer research in Germany, China, and Japan to determine pricing potential for the asset in each market 
• Synthesize findings to compare and contrast pricing potential in each regional and identify key factors that drive pricing decisions in each market